Currently, there are 455.34M common shares owned by the public and among those 424.97M shares have been available to trade.
The company’s stock has a 5-day price change of 1.89% and 18.06% over the past three months. GEHC shares are trading 18.97% year to date (YTD), with the 12-month market performance up to 34.72% higher. It has a 12-month low price of $62.35 and touched a high of $94.50 over the same period. GEHC has an average intraday trading volume of 2.82 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.69%, 8.45%, and 11.77% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of GE HealthCare Technologies Inc (NASDAQ: GEHC) shares accounts for 76.07% of the company’s 455.34M shares outstanding.
It has a market capitalization of $42.01B and a beta (3y monthly) value of 1.37. The stock’s trailing 12-month PE ratio is 26.69, while the earnings-per-share (ttm) stands at $3.45. The company has a PEG of 2.47 and a Quick Ratio of 0.77 with the debt-to-equity ratio at 1.24. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.48% over the week and 2.33% over the month.
Earnings per share for the fiscal year are expected to increase by 8.13%, and 11.47% over the next financial year. EPS should grow at an annualized rate of 10.80% over the next five years, compared to -2.54% over the past 5-year period.
Looking at the support for the GEHC, a number of firms have released research notes about the stock. UBS stated their Sell rating for the stock in a research note on September 26, 2024, with the firm’s price target at $84-$74. BTIG Research coverage for the GE HealthCare Technologies Inc (GEHC) stock in a research note released on September 18, 2024 offered a Buy rating with a price target of $100. JP Morgan was of a view on September 09, 2024 that the stock is Neutral, while Stifel gave the stock Buy rating on August 06, 2024, issuing a price target of $100. Goldman on their part issued Neutral rating on May 30, 2024.
